Citation:Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, et al 2010

Citation

Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, et al. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt. Urol Int 2010;84(2):141-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20215816.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, et al 2010	For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?	Suzanne Hughes	completed
Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, et al 2010 2	For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?	Tracy Tsang	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?|]] (compare critical appraisals)
• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?|]] (compare critical appraisals)

Cited by

1. PSA Testing strategies